For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260304:nRSD3653Va&default-theme=true
RNS Number : 3653V Polar Capital Global Health Tst PLC 04 March 2026
4(th) March 2026
Polar Capital Global Healthcare Trust plc (the "Company")
Top Ten Equity Holdings and Sector and Geographic Exposure as at 27(th)
February 2026.
Polar Capital Global Healthcare Trust plc is pleased to announce that as at
27(th) February 2026 the top ten equity holdings and the sector and geographic
breakdown were as follows:
Top 10 Holdings %
Eli Lilly & Co 8.9%
AstraZeneca 6.3%
Roche 5.7%
Chugai Pharmaceutical Co 4.9%
CVS Health Corp 4.7%
Thermo Fisher Scientific 4.4%
Cigna Corp 3.9%
Teva Pharmaceutical Industries 3.7%
Fresenius SE & Co NPV 3.6%
Genmab A/S 3.1%
Total 49.4%
Sector Exposure %
Pharmaceuticals 45.1%
Biotechnology 23.5%
Healthcare Services 15.6%
Life Sciences Tools & Services 7.8%
Healthcare Equipment 6.2%
Healthcare Supplies 3.1%
Managed Healthcare 3.1%
Healthcare Distributors 2.1%
Healthcare Technology 0.8%
Healthcare Facilities 0.0%
Cash -7.3%
Total 100.0%
Geographic Exposure %
United States 50.3%
United Kingdom 9.4%
Germany 8.7%
Denmark 8.0%
Switzerland 5.7%
Japan 5.7%
Israel 3.7%
Ireland 3.3%
Belgium 2.6%
India 2.6%
Netherlands 2.6%
China 2.2%
Sweden 1.5%
France 1.1%
Cash -7.3%
Total 100.0%
The monthly factsheet will usually be available on the Company's website on
the 10(th) working day after the month end and includes a commentary by the
investment manager. www.Polarcapitalhealthcaretrust.co
(http://www.Polarcapitalhealthcaretrust.com) m
(http://www.Polarcapitalhealthcaretrust.com)
Neither the contents of the Company's website nor the contents of any website
accessible from the hyperlinks on the Company's website (or any other website)
is incorporated into or forms part of this announcement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END PFUMZGGFKDFGVZM
Copyright 2019 Regulatory News Service, all rights reserved
Recent news on Polar Capital Global Healthcare Trust